- $156.05m
- $102.51m
- $42.17m
Brief: Coherus Biosciences Inc Sees Q4 Revenues Greater Than $90 Mln
Inovio rises on Coherus collaboration for HPV-related cancer therapy development
U.S. STOCKS ON THE MOVE-Coherus, Moderna
Coherus rises after launching throat cancer therapy
Brief: Coherus Announces U.S. Launch Of Loqtorzi™
Newscasts - Wall St ticks up, S&P 500 near all-time closing high
US STOCKS-Wall St ekes out modest gains as S&P 500 hovers near all-time closing high
US STOCKS-Wall St ekes out modest gains as S&P 500 hovers near all-time closing high
Newscasts - U.S. Day Ahead: Markets look ahead to key jobs data and pending home sales
Newscasts - Trading at Noon: S&P 500 closes in on its all-time high
Coherus rises on FDA approval for drug-delivery device
Brief: Coherus Announces FDA Approval Of UDENYCA ONBODY
U.S. STOCKS ON THE MOVE-Paramount Global, Enphase Energy, bluebird bio
U.S. STOCKS ON THE MOVE-VerifyMe, Coherus BioSciences, bluebird bio
U.S. STOCKS ON THE MOVE-Carrier Global, Qualcomm, Nikola
Coherus BioSciences falls after CFO resigns
Brief: Coherus Biosciences Announces CFO Transition Plans
Brief: Coherus Biosciences Inc CFO Mcdavid Stilwell To Resign
U.S. RESEARCH ROUNDUP-Caredx, Ebix, Vera Therapeutics